Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials.

The Journal of clinical psychiatry

Volumn 68, Issue 2, 2007, Pages

  Lieberman, Jeffrey A ^a  

^a Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CHRONIC DISEASE; COST BENEFIT ANALYSIS; DRUG COST; ECONOMICS; HUMAN; REVIEW; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; DRUG COSTS; HUMANS; SCHIZOPHRENIA;

EID: 33847713720     PISSN: None     EISSN: 15552101     Source Type: Journal    
DOI: None     Document Type: Review

References (7)